Key Takeaways
- Domestic crop care hit by extreme weather: Excessive rains, floods and waterlogging drove a 3% volume decline in domestic B2C, with herbicides and insecticides both degrowing as farmers missed applications and returns rose.
- Exports provided the offset: Export business delivered 51% H1 growth (INR312 crores vs INR207 crores), driven overwhelmingly by volume gains and new customer additions, though U.S. tariffs touched ~15% of formulation business.
- Seed margins transformed, but supply risks loom: Over 80% of H1 seed revenue came from own-research products, lifting margins materially; however, illegal HTBt cotton and maize supply-chain constraints pressured placement volumes.
- Soil and Plant Health hit by a regulatory storm: Bio-stimulant sales were disrupted when third-party suppliers lost permission to sell; management says the issues are now sorted and expects the disruption to benefit organized players going forward.
- What to watch next quarter: Whether the promised rabi recovery materializes, the pace of cotton seed volume expansion for Diggaz, and any stabilization in domestic crop protection pricing and liquidation.
Domestic Crop Protection: Weather Wrecks the Quarter
- Rainfall damage was severe and concentrated: Abnormal, uneven rainfall plus floods and waterlogging submerged large farmland areas in pre-agronomic consuming states, hitting soybean, maize, cotton and pulses. Heavy rain washed off pests, limited infestation, delayed harvesting and crop protection applications, and increased sales returns.
- Domestic B2C degrew 8% by value, 3% by volume: Herbicide liquidation in cotton and soybeans suffered most, leading to returns and overall volume degrowth; insecticides also registered degrowth as insects were washed away.
- Price took a bigger hit than volume: The market tendency to reduce prices and offer more schemes to pass benefits to farmers meant price impacted more than volume in the domestic decline.
- Disease, not insects, defined this kharif: Heavy rains washed insects away; disease was more prevalent. Crops still in the field are southern rice (planted late) and some cotton in the South; North and East seasons are over.
- Fertilizer shortage compounded receivables pressure: When fertilizer is in short supply, market money flows to fertilizer players first, creating an imbalance that pressures pesticide and seed company receivables and product placement.
Shukla: "when there's too much of fertilizer noise, it's a bad news for pesticide sector from a receivable perspective and your ability to place the product because you want some money before you place the product, but these shortages create some kind of imbalance in terms of movement of the money to different components of the business."
Export Business: Volume-Led Growth, Tariff Overhang
- H1 export revenue grew 51% YoY to INR312 crores: 85%-90% of the gain came from volume, with the remainder from efficiencies and price. Metribuzin and Hexaconazole showed good momentum, Pendimethalin is on a good track, and Acephate improved capacity utilization in H1.
- Customer phasing hit Q2 specifically: Q2 revenues were impacted by customer phasing-off of dispatch plans for key products, making the quarter look softer than the underlying trend.
- Geography mix is deepening, not broadening: The bulk of export business still comes from existing geographies, with new customers added in those same markets. Some growth came from newer geographies (France, Malaysia, Spain added this year) but those are early supplies.
- U.S. tariff exposure is contained but real: 85% of export business is technical supply not impacted by tariffs as of now; only 15% is formulation-based and exposed. One key CSM product used in aerospace (Boeing) faced challenges leading to order rescheduling, though CSM margins remain intact.
- Chinese displacement risk in Brazil: If the U.S. market remains restricted, Chinese players may push products into the Brazilian market; while volumes might grow, pricing pressure is possible.
Shukla: "U.S. is our primary business, right? Now U.S. has tariff challenges, but fortunately, for us, 85% of our business is technical supply that is not impacted by tariffs as of now. Only 15% of export business is impacted by tariff because it is formulation based, right?"
Seeds: Margin Inflection, Supply-Chain Headaches
- Own-research products drove a margin step-change: More than 80% of H1 seed revenue came from own-research products, resulting in significantly higher margins. As the business moves into Q3 and Q4 (rabi season, less than 20% of revenue), the mix skews toward partnership products where margins are lower.
- Bajra carries the highest margin: Cotton, maize and rice fall in the same margin bucket; cotton faces additional challenges from government price control.
- Maize supply chain constrained placement: Q2 witnessed significant supply-chain constraints for maize, particularly in Tamil Nadu and neighboring states; placement volume fell short of plan targets, mitigated through enhanced placement of mustard.
- Illegal HTBt cotton drove returns: Widespread adoption of illegal HTBt varieties resulted in higher returns for organized seed companies, pressuring the cotton seed business.
- Diggaz cotton hybrid has significant runway: Management is significantly pleased with the response and believes only 50%-60% of potential has been harnessed for Aatish and Diggaz; planned significant volume expansion for Diggaz and a newly launched cotton hybrid in the North, with clarity on volumes expected toward the end of Q3 after quality testing.
- Seed availability risk is crop-specific: No risk to mustard (limited players) and bajra; most challenges expected in cotton, rice and maize for the coming season.
Shukla: "I believe past is behind us. We are a very focused seed company now doing a few things. I believe that we should be able to sustain and grow our margins."
Soil and Plant Health: A Storm That May Clear the Field
- Two disruptions hit simultaneously: Farmers missed sprays due to extreme weather uncertainty, and some bio-stimulant products dependent on third-party suppliers were unable to secure permission to sell. Biofertilizer business was also impacted by excessive rain making open-field processing difficult.
- All issues are now sorted: Management confirmed that the regulatory and raw-material supply challenges have been resolved.
- The disruption may benefit organized players: The regulatory tightening should bring clarity and reduce the number of players, creating better prospects for organized companies like Rallis.
- Soil and Plant Health carries the highest gross margins among Rallis's segments, followed by seeds; CSM margins are higher where present; margin challenges are concentrated in export business and domestic institutional business.
Shukla: "There was a storm in quarter 2, if I can use the more appropriate word, but this should lead to better prospects for organized players like us in the future."
Product Pipeline & R&D: Narrower Focus, Sharper Execution
- 8 new products launched year-to-date: Including herbicides 'Deeweed' and fungicide 'Dodrio' in Q2. One product launch was delayed because management was not happy with formulation quality; that problem is fixed and the product will be introduced as a broader-spectrum insecticide.
- 3 new seed hybrids launched: One each in cotton, rice and maize; all three have done very well.
- Test-launch products from Q4 FY25 have more than doubled volume YTD, indicating good traction and momentum in the market.
- R&D has been refocused: Vegetable R&D has been stopped; less focus on GM crops; now concentrating on modern breeding tools that are biotechnology-driven but not GM. Securing 9(3) registrations, with management pleased on progress.
- Next launches: A wheat herbicide and a rice herbicide are expected next.
- Annual R&D spend runs INR60-70 crores, per management.
Shukla: "A lot of things we were doing, we have stopped, right? For example, we don't do any vegetable R&D now. We are less focusing on GM crops. Now we are focusing more on modern breeding tools, which are biotechnology driven, but are not GM crops."
Industry Context & Near-Term Outlook
- Global signals show cautious optimism: Gradual demand improvement supported by stable pricing and strong export demand from the U.S. and Brazil, though industry margins are likely to remain subdued amid rising competition and U.S. tariffs on Chinese agrochemical imports.
- Kharif area up, production likely down: Though overall kharif area increased, productivity is expected to drop due to weather damage. A possible 10%-15% spillover of kharif season into October is expected from extended rabi-season crops.
- Rabi prospects look slightly better: Residual moisture should lead to a better rabi crop if conditions continue; planting should be good. Once fertilizer planting resolves, farmers will shift focus back to crop protection.
- Industry likely grew low-to-mid single digits in H1, though management cautioned it is too early to comment precisely as many numbers are yet to come.
- U.S. channel inventory is normalized: No pressure on demand, only pressure on prices.
- Regulatory tightening brings clarity: Efforts to regulate the market better reduce the number of players, which benefits organized companies.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Capex spend | Around INR50 crores | FY26 |
| Seed margin trajectory | Sustain and grow margins from current levels | Ongoing |
| Cotton seed volume expansion | Significant volume expansion for Diggaz and new North hybrid; clarity on volumes after quality testing | End of Q3 FY26 |
| Soil and Plant Health recovery | Normal business recovery expected; issues sorted | From Q3 FY26 onward |
| New product launches | Wheat herbicide and rice herbicide next in pipeline | Undated (next in sequence) |
| R&D progress summary | Comprehensive summary of R&D progress to be shared | End of FY26 or early FY27 |
| Seed business focus | Gradually build presence across 5 key crops (cotton, maize, millet, mustard, rice) with profitability focus | Ongoing |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Revenue | ₹861 cr, -7% YoY vs ₹928 cr in Q2 FY25 |
| EBITDA | ₹154 cr, -7% YoY vs ₹166 cr in Q2 FY25 |
| Profit after tax | ₹102 cr, +4% YoY vs ₹98 cr in Q2 FY25; 120 bps higher |
| Overall volume degrowth | 6% YoY |
| Overall price degrowth | 1% YoY |
| Crop Care segment revenue degrowth | 3% YoY |
| Domestic B2C revenue degrowth | 8% YoY; volume degrowth of 3% |
| Domestic branded business decline | 10% YoY |
| Export revenue growth | 33% YoY; Q2 export revenue at ₹161 cr |
| H1 export revenue | ₹312 cr, +51% YoY vs ₹207 cr in H1 FY25 |
| Seeds segment revenue | ₹101 cr, -29% YoY vs ₹141 cr in Q2 FY25 |
| Soil and Plant Health annual revenue (FY25) | ₹225 cr; H1 FY26 flat vs planned 20% growth |
| Cash and liquid balance | ₹454 cr as of 30 September 2025 |
| Capex guidance | ~₹50 cr |
| R&D annual budget | ₹60–70 cr |